BioSpace News Archive

FDA

Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Primary Vitreoretinal Lymphoma

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company for ADX-2191 (methotrexate for intravitreal injection) for the treatment of primary vitreoretinal lymphoma (PVRL).

July 20, 2021
·
7 min read
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed

Femasys Inc. today announced the initiation and first patient treated in a pivotal trial evaluating FemaSeed, a first in class, localized directional insemination product candidate for infertility.

July 20, 2021
·
4 min read
BioMidwest

Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the 2021 ASCRS (American Society of Cataract and Refractive Surgery) Annual Meeting

- Data presentations highlight Phase 3 GEMINI 1 trial results on the safety and efficacy of investigational AGN-190584 (pilocarpine 1.25%) as a potential novel treatment for presbyopia, a common and progressive eye condition that reduces the eye’s ability to focus on near objects

July 20, 2021
·
8 min read
Lone Star Bio

Genprex to Participate in a Monthly CEO Roadshow Webinar Series

Series to highlight Genprex’s novel gene therapy pipeline in cancer and diabetes

July 20, 2021
·
5 min read
Business

Neogen Reports Record Revenues for Fiscal 2021

Neogen Corporation (NASDAQ: NEOG) announced today the results for its fourth quarter and full 2021 fiscal year, which ended May 31, 2021.

July 20, 2021
·
9 min read
Drug Development

KeifeRx Receives FDA Acceptance of Investigational New Drug for Phase 3 Study of Nilotinib BE in Early Alzheimer’s Disease

KeifeRx, LLC announced today that the company received an acceptance of its Investigational New Drug (IND) application from the United States Food and Drug Administration (FDA) to launch a Phase 3 trial named NILEAD for Nilotinib BE.

July 20, 2021
·
2 min read
Business

Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021

Stereotaxis today announced that it will release financial results for its 2021 second quarter on Tuesday, August 10, 2021 before the open of the U.S. financial markets.

July 20, 2021
·
1 min read
Biotech Beach

Terasaki Institute for Biomedical Innovation and Tetratherix™ Form Collaboration

The Terasaki Institute for Biomedical Innovation (TIBI) has formally signed a collaborative agreement with Tetratherix™, a company which produces Tetramatrix, a synthetic injectable hydrogel currently being clinically tested in a variety of biomedical applications.

July 20, 2021
·
2 min read
Business

OnKure Builds its Discovery Team and Appoints Heads of Computational Drug Discovery and Pharmacology

OnKure, Inc. announced the appointment of two key members to its drug discovery team, James Blake, Ph.D., Senior Vice President of Computational Drug Discovery, and Richard Woessner, Ph.D., Senior Vice President of Pharmacology.

July 20, 2021
·
3 min read
Biotech Bay

Leading Medical Device Companies Leverage Parasoft to Continuously Evolve Embedded Software Development Workflow

Parasoft, a global leader in automated software testing for over 30 years, partnered with medical industry leaders, Smiths Medical and Inovytec, to help streamline the delivery of life-saving medical devices using its unified, fully integrated testing solution for C/C++ software development.

July 20, 2021
·
3 min read